Profund Advisors’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $197K | Buy |
42,080
+21,888
| +108% | +$102K | 0.01% | 911 |
|
|
2025
Q1 | $111K | Sell |
20,192
-2,777
| -12% | -$15.2K | ﹤0.01% | 945 |
|
|
2024
Q4 | $77.9K | Buy |
22,969
+227
| +1% | +$770 | ﹤0.01% | 1084 |
|
|
2024
Q3 | $64.8K | Sell |
22,742
-1,978
| -8% | -$5.64K | ﹤0.01% | 1125 |
|
|
2024
Q2 | $55.6K | Sell |
24,720
-3,655
| -13% | -$8.22K | ﹤0.01% | 1065 |
|
|
2024
Q1 | $62.7K | Buy |
+28,375
| New | +$62.7K | ﹤0.01% | 1140 |
|